Maryleen Lovell-Petronilia is a Medical Biologist specializing in Molecular Pathology, with over 13 years of experience in clinical research and healthcare. In 2022, after a decade in research and innovation, where she introduced risk management documentation in routine clinical diagnostics, Maryleen transitioned to the role of Manager of Quality Assurance and Compliance at PCM Trials. In this position, she focuses on enhancing quality oversight and ensuring compliance with regulatory requirements and country-specific regulations.
Maryleen is committed to advancing the global adoption of patient-centric approaches and fostering collaboration among stakeholders to promote and uphold high standards in decentralized clinical trials